Show
Sort by
-
Goodbye to the term ‘ankylosing spondylitis’, hello ‘axial spondyloarthritis’: time to embrace the ASAS-defined nomenclature
-
Upadacitinib for the treatment of active non-radiographic axial spondyloarthritis (SELECT-AXIS 2) : a randomised, double-blind, placebo-controlled, phase 3 trial
-
- Journal Article
- A1
- open access
Axial involvement in psoriatic arthritis : an update for rheumatologists
-
- Journal Article
- A1
- open access
Continuing versus withdrawing ixekizumab treatment in patients with axial spondyloarthritis who achieved remission : efficacy and safety results from a placebo-controlled, randomised withdrawal study (COAST-Y)
-
Data-driven definitions for active and structural MRI lesions in the sacroiliac joint in spondyloarthritis and their predictive utility
-
- Journal Article
- A1
- open access
Secukinumab in non-radiographic axial spondyloarthritis : subgroup analysis based on key baseline characteristics from a randomized phase III study, PREVENT
-
- Journal Article
- A1
- open access
Monocyte transcriptomes from patients with axial spondyloarthritis reveal dysregulated monocytopoiesis and a distinct inflammatory imprint
-
- Journal Article
- A1
- open access
Axial involvement in psoriatic arthritis cohort (AXIS) : the protocol of a joint project of the Assessment of SpondyloArthritis international Society (ASAS) and the Group for Research and Assessment of Psoriasis and Psoriatic Arthritis (GRAPPA)
-
Central reader evaluation of MRI scans of the sacroiliac joints from the ASAS classification cohort : discrepancies with local readers and impact on the performance of the ASAS criteria
-
- Journal Article
- A1
- open access
EULAR recommendations for the management of psoriatic arthritis with pharmacological therapies : 2019 update